Pope Francis plans to appear at the ESC Congress 2016 to endorse the group's healthy lifestyle campaign.
Poushali Mukherjea, PhD, Executive Director, Global Medical Affairs, Bristol-Myers Squibb, noted some key takeaways from her team’s 19 abstracted slated to be presented at the European Society of Cardiology Congress 2016 (ESC).
Statins should not be physicians' first option in treating all patients at high risk of cardiovascular disease, according to new European treatment guidelines.
Sonal Bhatia, MD, Vice President, Global Eliquis Medical Lead, Pfizer, highlighted the significance of the consistency in data over the last five years, in relation to the five-year-anniversary of her team's Aristotle study at the European Society of Cardiology 2016 (ESC).
An international team looked at oral anticoagulants and decided dabigatran is the best for stroke prevention in non-valvular atrial fibrillation.
Percutaneous balloon mitral valvulopasty (PMV) has now been around long enough for long term outcomes to be assessed. The verdict is positive.
Data mining may be a promising method to search for unknown drug-drug interactions in cardiovascular medicine.
Lung cancer patients who develop sinus tachycardia due to some treatments for their cancer can successfully reduce their heart rates with ivabradine, researchers in Romania report.
Emerging more frequently as part of the total evidence generated with Eliquis, real-world data allows researchers to work with larger populations to show specific reductions in major bleeding and stroke, as well.